This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sorenson, C. M. Articles by Eastman, A. Search for Related Content PubMed PubMed Citation Articles by Sorenson, C. M. Articles by Eastman, A.

Mechanism of cis-Diamminedichloroplatinum(II)-induced Cytotoxicity: Role of G₂ Arrest and DNA Double-Strand Breaks¹

Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105

DNA has been implicated as the critical target for cis-diamminedichloroplatinum(II) (cis-DDP)-induced cytotoxicity. In vitro, DNA-platinum adducts inhibit DNA synthesis. An assessment of the inhibition of DNA synthesis in murine leukemia L1210 cells demonstrated that, although cell division was halted, DNA replication continued for a period of time. The DNA underwent almost a complete doubling even in cells that did not divide. Flow cytometric analysis demonstrated a slowed synthetic phase which progressed to a block in the G₂ phase of the cell cycle. The duration of the G₂ block was proportional to the concentration of cis-DDP. Low concentrations of cis-DDP caused the cells to be transiently blocked in the G₂ phase for 24 to 48 h. Higher concentrations of cis-DDP resulted in a G₂ arrest that was not reversed by 96 h. After this time, the arrested cells appeared to disintegrate, rather than recover. Cell survival and trypan blue exclusion studies indicated that, at low drug concentrations, cells which had transiently arrested in the G₂ phase survived, while at higher concentrations only a limited number of survivors were responsible for the observed recovery of growth. Analysis of DNA double-strand breaks showed that significant numbers of breaks only occurred at concentrations of cis-DDP that subsequently led to debris detectable on the flow cytometer and to loss of trypan blue exclusion. The formation of these breaks appeared to be the first detectable change that was indicative of cell death. It is proposed that cells arrest in the G2 phase because they are unable to transcribe damaged DNA and make mRNA essential for passage into mitosis. DNA repair probably overcomes this arrest. Cell death may therefore be a consequence of the inability to adequately recover transcription.

¹ This work was supported by National Cancer Institute Research Grants CA36039 and CA00906 and by Cancer Center Support Grant CA36727. C. M. S. was supported by a fellowship from the Elizabeth Bruce and Parents Memorial Endowment.

² To whom requests for reprints should be addressed.

Received 8/18/87. Revised 3/ 7/88. Revised 5/ 4/88. Accepted 5/11/88.

This article has been cited by other articles:

				F. Yu, J. Megyesi, and P. M. Price Cytoplasmic initiation of cisplatin cytotoxicity Am J Physiol Renal Physiol, July 1, 2008; 295(1): F44 - F52. [Abstract] [Full Text] [PDF]

				Y. Yokoyama, B. Xin, T. Shigeto, M. Umemoto, A. Kasai-Sakamoto, M. Futagami, S. Tsuchida, F. Al-Mulla, and H. Mizunuma Clofibric acid, a peroxisome proliferator-activated receptor {alpha} ligand, inhibits growth of human ovarian cancer Mol. Cancer Ther., April 1, 2007; 6(4): 1379 - 1386. [Abstract] [Full Text] [PDF]

				A. A. Levesque and A. Eastman p53-based cancer therapies: is defective p53 the Achilles heel of the tumor? Carcinogenesis, January 1, 2007; 28(1): 13 - 20. [Abstract] [Full Text] [PDF]

				P. Pichierri, A. Franchitto, R. Piergentili, C. Colussi, and F. Palitti Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair Carcinogenesis, November 1, 2001; 22(11): 1781 - 1787. [Abstract] [Full Text] [PDF]

				M. A. Shah and G. K. Schwartz Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181. [Abstract] [Full Text] [PDF]

				T. Furui, R. LaPushin, M. Mao, H. Khan, S. R. Watt, M.-A. V. Watt, Y. Lu, X. Fang, S. Tsutsui, Z. H. Siddik, et al. Overexpression of Edg-2/vzg-1 Induces Apoptosis and Anoikisin Ovarian Cancer Cells in a Lysophosphatidic Acid-independent Manner Clin. Cancer Res., December 1, 1999; 5(12): 4308 - 4318. [Abstract] [Full Text] [PDF]

				B. J. Maurer, M. A. Ihnat, C. Morgan, J. Pullman, C. O'Brien, S. W. Johnson, J. S. Rasey, and M. M. Cornwell Growth of Human Tumor Cells in Macroporous Microcarriers Results in p53-Independent, Decreased Cisplatin Sensitivity Relative to Monolayers Mol. Pharmacol., May 1, 1999; 55(5): 938 - 947. [Abstract] [Full Text]

				G. S. Hagopian, G. B. Mills, A. R. Khokhar, R. C. Bast Jr., and Z. H. Siddik Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the Novel Platinum Analogue (1R, 2R-Diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV) Clin. Cancer Res., March 1, 1999; 5(3): 655 - 663. [Abstract] [Full Text] [PDF]

				S. J. Morana, C. M. Wolf, J. Li, J. E. Reynolds, M. K. Brown, and A. Eastman The Involvement of Protein Phosphatases in the Activation of ICE/CED-3 Protease, Intracellular Acidification, DNA Digestion, and Apoptosis J. Biol. Chem., July 26, 1996; 271(30): 18263 - 18271. [Abstract] [Full Text] [PDF]

				J. Li and A. Eastman Apoptosis in an Interleukin-2-dependent Cytotoxic T Lymphocyte Cell Line Is Associated with Intracellular Acidification J. Biol. Chem., February 17, 1995; 270(7): 3203 - 3211. [Abstract] [Full Text] [PDF]